These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29393426)

  • 1. Endoglin (CD105) and SMAD4 regulate spheroid formation and the suppression of the invasive ability of human pancreatic cancer cells.
    Kokaji E; Shimomura A; Minamisaka T; Nakajima T; Miwa S; Hatta H; Nishida T; Kiya C; Imura J
    Int J Oncol; 2018 Mar; 52(3):892-900. PubMed ID: 29393426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling.
    Fullerton PT; Creighton CJ; Matzuk MM
    Mol Endocrinol; 2015 Oct; 29(10):1440-53. PubMed ID: 26284758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
    Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M
    Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-362 negatively and positively regulates SMAD4 expression in TGF-β/SMAD signaling to suppress cell migration and invasion.
    Cheng HP; Huang CJ; Tsai ML; Ong HT; Cheong SK; Choo KB; Chiou SH
    Int J Med Sci; 2021; 18(8):1798-1809. PubMed ID: 33746597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells.
    Zhao S; Ammanamanchi S; Brattain M; Cao L; Thangasamy A; Wang J; Freeman JW
    J Biol Chem; 2008 Apr; 283(17):11293-301. PubMed ID: 18310076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.
    Rose M; Meurer SK; Kloten V; Weiskirchen R; Denecke B; Antonopoulos W; Deckert M; Knüchel R; Dahl E
    Mol Carcinog; 2018 Feb; 57(2):167-181. PubMed ID: 28940371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.
    Yasutome M; Gunn J; Korc M
    Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells.
    Duda DG; Sunamura M; Lefter LP; Furukawa T; Yokoyama T; Yatsuoka T; Abe T; Inoue H; Motoi F; Egawa S; Matsuno S; Horii A
    Oncogene; 2003 Oct; 22(44):6857-64. PubMed ID: 14534532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of Smad4 by miR‑205 moderates TGF-β-induced epithelial-mesenchymal transition in A549 cell lines.
    Zeng Y; Zhu J; Shen D; Qin H; Lei Z; Li W; Huang JA; Liu Z
    Int J Oncol; 2016 Aug; 49(2):700-8. PubMed ID: 27279345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1.
    Hoshino Y; Nishida J; Katsuno Y; Koinuma D; Aoki T; Kokudo N; Miyazono K; Ehata S
    Am J Pathol; 2015 May; 185(5):1457-70. PubMed ID: 25769430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/ Smad4 axis driving the cells towards lethal EMT.
    Mohd Faheem M; Rasool RU; Ahmad SM; Jamwal VL; Chakraborty S; Katoch A; Gandhi SG; Bhagat M; Goswami A
    Eur J Cell Biol; 2020 May; 99(4):151076. PubMed ID: 32439219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer.
    Togashi Y; Sakamoto H; Hayashi H; Terashima M; de Velasco MA; Fujita Y; Kodera Y; Sakai K; Tomida S; Kitano M; Ito A; Kudo M; Nishio K
    Mol Cancer; 2014 May; 13():126. PubMed ID: 24886203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis.
    Voorneveld PW; Stache V; Jacobs RJ; Smolders E; Sitters AI; Liesker A; Korkmaz KS; Lam SM; De Miranda NF; Morreau H; Kodach LL; Hardwick JC
    Br J Cancer; 2013 Oct; 109(7):1805-12. PubMed ID: 23969729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The zinc transporter LIV-1 is a novel regulator of stemness in pancreatic cancer cells.
    Unno J; Masamune A; Hamada S; Shimosegawa T
    Scand J Gastroenterol; 2014 Feb; 49(2):215-21. PubMed ID: 24294832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between S100A11 and the TGF-β
    Ji YF; Li T; Jiang F; Ni WK; Guan CQ; Liu ZX; Lu CH; Ni RZ; Wu W; Xiao MB
    Mol Cell Biochem; 2019 Jan; 450(1-2):53-64. PubMed ID: 29922945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L; Hill CS
    Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system.
    Wiercinska E; Naber HP; Pardali E; van der Pluijm G; van Dam H; ten Dijke P
    Breast Cancer Res Treat; 2011 Aug; 128(3):657-66. PubMed ID: 20821046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
    Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
    Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.